Showing results (941-950 of 1,038) with videos related to

Sort By:
Pageof 104
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanomaFederica Catalanotti, David B Solit, Melissa P Pulitzer, et al.
Frontiers in Oncology|October 17, 2022
Intermittent MEK inhibition for the treatment of metastatic uveal melanomaShaheer Khan, Sapna P Patel, Alexander N Shoushtari, et al.
British Journal of Cancer|October 29, 2011
Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control studyJ N Hofmann, A Baccarelli, K Schwartz, et al.
Investigational New Drugs|May 13, 2010
A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumorsMark Andrew Dickson, Dana E Rathkopf, Richard D Carvajal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.
Cancer|April 8, 2014
Patient-derived xenografts for individualized care in advanced sarcomaJustin Stebbing, Keren Paz, Gary K Schwartz, et al.
Neoplasia (New York, N.Y.)|March 10, 2015
Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcomeJoyce N Barlin, Qin C Zhou, Mario M Leitao, et al.
Pageof 104